Freezing Plus Immunotherapy for Advanced Soft Tissue Sarcoma
Part of Cancer clinical trials.
This trial combines cryoablation (a freezing technique to destroy tumors) with camrelizumab (an immunotherapy drug that helps your immune system fight cancer) for patients with advanced soft tissue sarcoma that hasn't responded to standard treatments. The goal is to see if this combination works better than current options.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 14 and 70 years old
- You have a confirmed diagnosis of soft tissue sarcoma that is advanced or cannot be surgically removed
- Your cancer has not responded to or has failed standard treatments like chemotherapy
- You have at least 3 measurable tumors (1–5 cm each) in 3 or fewer organ areas
- Your blood work and heart function tests are within acceptable ranges
- You can visit the research center regularly for monitoring and treatment
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a personalized vaccine made from your tumor's unique mutations, combined with special immune cells grown from your blood, to treat advanced sarcoma (bone or soft tissue cancer) that did not respond to initial treatment. The goal is to help your immune system recognize and attack cancer cells.
This trial tests a new way of giving radiation therapy (called spatially fractionated radiotherapy) combined with a treatment strategy called PraG (pembrolizumab and granulocyte-macrophage colony-stimulating factor) for people with soft tissue sarcoma that cannot be removed or has spread. The goal is to see if the combination can help shrink or control the cancer.
This trial tests a new combination therapy: an injected virus (OVV-01) alongside an immunotherapy drug (AK112) for people with advanced soft tissue sarcoma that hasn't responded to usual treatments. The aim is to see if this approach can help shrink tumors or slow their growth.
This trial tests a combination of radiation therapy and two drugs (anlotinib and penpulimab) given before surgery for soft tissue sarcoma. The goal is to see if this approach can shrink tumors and improve outcomes.
This trial tests a new drug, HS-20093, combined with other treatments for people with advanced bone or soft tissue sarcoma. The goal is to see if these combinations can shrink tumors or slow their growth.
This trial tests a new approach for people with a rare type of cancer called retroperitoneal sarcoma, which grows in the back of the belly. It combines a short course of radiation and an immunotherapy drug before surgery, aiming to shrink the tumor and improve the chances of successful removal.
Hear when a new Osteosarcoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.